Noffisat O. Oki

Multifactor Dimensionality Reduction as a Filter-Based Approach for Genome Wide Association Studies

Alison A. Motsinger-Reif, Noffisat O. Oki, A. Motsinger-Reif, 2011, Front. Gene..

Accelerating Adverse Outcome Pathway Development Using Publicly Available Data Sources

Stephen W. Edwards, Holly M. Mortensen, Noffisat O. Oki, 2016, Current Environmental Health Reports.

Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study

Noffisat O. Oki, S. Levy, S. Holland, 2011, BMC Research Notes.

Alterations in metabolic pathways and networks in Alzheimer's disease

Noffisat O. Oki, J Q Trojanowski, J. Trojanowski, 2013, Translational Psychiatry.

An integrative data mining approach to identifying adverse outcome pathway signatures.

Stephen W. Edwards, Stephen W Edwards, Noffisat O. Oki, 2016, Toxicology.

A semi-automated workflow for adverse outcome pathway hypothesis generation: The use case of non-genotoxic induced hepatocellular carcinoma.

Thomas E. Exner, Noffisat O. Oki, T. Exner, 2020, Regulatory toxicology and pharmacology : RTP.

Tiered Approaches to Incorporate the Adverse Outcome Pathway Framework into Chemical-Specific Risk-Based Decision Making

Noffisat Oki, Jeremy A. Leonard, Mark Nelms, 2018 .

Integrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver models.

Barry Hardy, Thomas E. Exner, Pekka Kohonen, 2019, Toxicology in vitro : an international journal published in association with BIBRA.

Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans

Noffisat O. Oki, Daniel M. Rotroff, O. Fiehn, 2016, Front. Pharmacol..

Extrapulmonary tuberculosis

Noffisat O. Oki, S. Levy, S. Holland, 2015, Radiopaedia.org.